United States · Series B startup

Who invested in Centerline Biomedical

2 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 5 Nov 2026

$35Mraised across 2 rounds since 2015, from 2 sources

$1.7MSeed$33MSeries B
Latest round
Series B, $33MJun 2022
Step-upi
19.4×
Investors
0
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2016201720182019202020212022
$1.7MSeed$33MSeries B
First round
Seed, $1.7M
Aug 2015
Biggest round
$33M
Series B · Jun 2022
Between rounds
6.8 years
from the last two

The rounds

  1. Jun 2022
    Series B$33M

    No investor was named in the report.

    Source recorded

  2. Aug 2015
    Seed$1.7M

    No investor was named in the report.

    From a historical funding record

Also claim to have backed them

This firm lists Centerline Biomedical as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Device of Tomorrow CapitalInvestment firmPer its own site

Quick answers about Centerline Biomedical

How much has Centerline Biomedical raised?

Centerline Biomedical has raised $35M across 2 rounds since 2015.

When did Centerline Biomedical last raise?

Centerline Biomedical's most recent round was a Series B of $33M in Jun 2022.

What was Centerline Biomedical's biggest round?

Its most recent round, $33M in Jun 2022, is also its largest on record.

What stage is Centerline Biomedical at?

Centerline Biomedical's latest named round is a Series B, in Jun 2022.

Where is Centerline Biomedical based?

Centerline Biomedical is based in the United States.

Companies like Centerline Biomedical

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.